CHINA NATIONAL MEDICINES CORPORATION LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.64 CNY | -0.69% |
|
-2.31% | +21.03% |
| Mar. 21 | China Stocks Muted at Close as Recovery Optimism Fades; Sinopharm Jumps 6% on Upbeat 2023 Earnings | MT |
| Mar. 21 | Sinopharm's 2023 Profit Climbs 9%; Shares Up 6% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
China National Medicines Corporation Ltd. is a China-based company principally engaged in the distribution of pharmaceutical products. The Company's primary products include proprietary Chinese medicines, chemical medicine preparations, chemical raw materials, antibiotics, biochemical drugs, biological products, narcotic drugs, psychotropic drugs, vaccines and health foods, among others. The Company is also involved in the production of pharmaceuticals and the provision of warehousing services through its subsidiaries.
Sector
Pharmaceuticals
Calendar
09:30pm
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
34.64
CNY
Average target price
42.3
CNY
Spread / Average Target
+22.11%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +21.03% | 3.61B | |
| +15.65% | 70.36B | |
| +2.72% | 25.18B | |
| +5.62% | 8.61B | |
| +6.10% | 8.14B | |
| -21.85% | 7.83B | |
| +0.73% | 4.56B | |
| +17.40% | 4.32B | |
| -0.14% | 4.06B | |
| -2.34% | 3.87B |
- Stock Market
- Equities
- 600511 Stock
- News China National Medicines Corporation Ltd.
- China National Medicines' H1 Net Profit Rises 13%
